1177
Patients treated with 5-ASA compounds who experience acute inflammatory symptoms or clinical deterioration not related to their gastrointestinal disease should be screened to rule out a lupus-like reaction.
 ( adverse event: experience ,  Patients: Subject, who experience acute inflammatory symptoms or clinical deterioration not related to their gastrointestinal disease: Subject, lupus-like reaction: Effect, 5-ASA compounds: Treatment, 5-ASA: Treatment.Drug, gastrointestinal disease: Treatment.Disorder) 
Locate the role in the text that participated in the event based on the event type and return it in the event list. 
 Option: Event type: adverse event,potential therapeutic event, Arguments type: Treatment.Disorder,Treatment.Time_elapsed,Treatment.Dosage,Subject.Race,Treatment.Drug,Treatment.Route,Subject.Disorder,Treatment.Freq,Treatment,Effect,Subject.Population,Treatment.Duration,Combination.Drug,Subject,Subject.Age,Subject.Gender. 
Text: {0} 
Answer:
 ( adverse event: experience ,  Patients: Subject, who experience acute inflammatory symptoms or clinical deterioration not related to their gastrointestinal disease: Subject, lupus-like reaction: Effect, 5-ASA compounds: Treatment, 5-ASA: Treatment.Drug, gastrointestinal disease: Treatment.Disorder) 